NLRP3 Inflammasome in Atherosclerosis: Putting Out the Fire of Inflammation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NLRP3 Inflammasome in Atherosclerosis: Putting Out the Fire of Inflammation
Authors
Keywords
-
Journal
INFLAMMATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-12
DOI
10.1007/s10753-022-01725-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammation Resolution: Implications for Atherosclerosis
- (2022) Amanda C. Doran CIRCULATION RESEARCH
- Salvianolic acid A suppresses CCl4-induced liver fibrosis through regulating the Nrf2/HO-1, NF-κB/IκBα, p38 MAPK, and JAK1/STAT3 signaling pathways
- (2022) Shengnan Li et al. DRUG AND CHEMICAL TOXICOLOGY
- Interferon regulatory factor-5-dependent CD11c+ macrophages contribute to the formation of rupture–prone atherosclerotic plaques
- (2022) Andreas Edsfeldt et al. EUROPEAN HEART JOURNAL
- Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
- (2022) Gracia Fahed et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3
- (2022) Inga V. Hochheiser et al. NATURE
- Atherosclerosis: Known and unknown
- (2022) Jianglin Fan et al. PATHOLOGY INTERNATIONAL
- Mechanism of Dihydromyricetin on Inflammatory Diseases
- (2022) Yang Sun et al. Frontiers in Pharmacology
- Autophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis
- (2022) Lin Lin et al. Frontiers in Cell and Developmental Biology
- Recent update on application of dihydromyricetin in metabolic related diseases
- (2022) Yirong Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Autophagy in Atherosclerosis: Not All Foam Cells Are Created Equal
- (2022) Gordon A. Francis et al. CIRCULATION RESEARCH
- Lipoxin A4 and its analog attenuate high fat diet-induced atherosclerosis via Keap1/Nrf2 pathway
- (2022) Fen Xu et al. EXPERIMENTAL CELL RESEARCH
- The Expanding Role of Extracellular Traps in Inflammation and Autoimmunity: The New Players in Casting Dark Webs
- (2022) Stephanie U-Shane Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Baicalin Alleviates Short-Term Lincomycin-Induced Intestinal and Liver Injury and Inflammation in Infant Mice
- (2022) Shunfen Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The genetics behind inflammasome regulation
- (2022) Suemy Melim Yamada et al. MOLECULAR IMMUNOLOGY
- Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation
- (2022) Hongxia Li et al. Frontiers in Immunology
- New Insights Into the Interplay Among Autophagy, the NLRP3 Inflammasome and Inflammation in Adipose Tissue
- (2022) Liyuan Zhu et al. Frontiers in Endocrinology
- Specific NLRP3 Inflammasome Assembling and Regulation in Neutrophils: Relevance in Inflammatory and Infectious Diseases
- (2022) Christophe Paget et al. Cells
- Therapeutic Targeting of GSK3β-Regulated Nrf2 and NFκB Signaling Pathways by Salvianolic Acid A Ameliorates Peritoneal Fibrosis
- (2022) Fan Zhou et al. Frontiers in Medicine
- Low-dose dexamethasone in combination with luteolin improves myocardial infarction recovery by activating the antioxidative response
- (2022) Haitao Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Mitochondrial DNA in NLRP3 inflammasome activation
- (2022) Yanbing Qiu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Amelioration of type 2 diabetes by the novel 6, 8-guanidyl luteolin quinone-chromium coordination via biochemical mechanisms and gut microbiota interaction
- (2022) Xiaodong Ge et al. Journal of Advanced Research
- The NLRP3 inflammasome: Multiple activation pathways and its role in primary cells during ventricular remodeling
- (2021) Zhipeng Yan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Epigenetic Remodeling in Innate Immunity and Inflammation
- (2021) Qian Zhang et al. Annual Review of Immunology
- Novel insights: Dynamic foam cells derived from the macrophage in atherosclerosis
- (2021) Jun Li et al. JOURNAL OF CELLULAR PHYSIOLOGY
- NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
- (2021) Eleonora Mezzaroma et al. MOLECULES
- NLRP3 inflammasome in cancer and metabolic diseases
- (2021) Bhesh Raj Sharma et al. NATURE IMMUNOLOGY
- Anti-NLRP3 Inflammasome Natural Compounds: An Update
- (2021) Baolong Liu et al. Biomedicines
- An update on the regulatory mechanisms of NLRP3 inflammasome activation
- (2021) Seungwha Paik et al. Cellular & Molecular Immunology
- The changing landscape of atherosclerosis
- (2021) Peter Libby NATURE
- Targeting inflammation in atherosclerosis — from experimental insights to the clinic
- (2021) Oliver Soehnlein et al. NATURE REVIEWS DRUG DISCOVERY
- Cardiovascular effects of approved drugs for rheumatoid arthritis
- (2021) Fabiola Atzeni et al. Nature Reviews Rheumatology
- Pyroptosis is a critical immune-inflammatory response involved in atherosclerosis
- (2021) Xiao He et al. PHARMACOLOGICAL RESEARCH
- Inflammation and Atherosclerosis
- (2021) Klaus Ley Cells
- Humoral immunity in atherosclerosis and myocardial infarction: from B cells to antibodies
- (2021) Florentina Porsch et al. CARDIOVASCULAR RESEARCH
- NLRP3 inflammasome activation and cell death
- (2021) Yi Huang et al. Cellular & Molecular Immunology
- Autophagy in major human diseases
- (2021) Daniel J Klionsky et al. EMBO JOURNAL
- Time-restricted eating for the prevention and management of metabolic diseases
- (2021) Emily N Manoogian et al. ENDOCRINE REVIEWS
- Cell biology of inflammasome activation
- (2021) Abhimanu Pandey et al. TRENDS IN CELL BIOLOGY
- The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease
- (2021) Ruixue Kong et al. AUTOIMMUNITY
- Metabolism of tissue macrophages in homeostasis and pathology
- (2021) Stefanie K. Wculek et al. Cellular & Molecular Immunology
- Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis
- (2021) Lei Qiao et al. CIRCULATION RESEARCH
- Innate Immunity
- (2021) Bani Preet Kaur et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Desmosterol suppresses macrophage inflammasome activation and protects against vascular inflammation and atherosclerosis
- (2021) Xinbo Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease
- (2021) Jerry R. Colca et al. Molecular Metabolism
- Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis via the TFEB–P300–BRD4 axis
- (2021) Xuesong Li et al. Acta Pharmaceutica Sinica B
- Therapeutic Effect of Schistosoma japonicum Cystatin on Atherosclerotic Renal Damage
- (2021) Huijuan Yang et al. Frontiers in Cell and Developmental Biology
- Anti-inflammatory effects of artesunate on atherosclerosis via miR-16-5p and TXNIP regulation of the NLRP3 inflammasome
- (2021) Bo Li et al. Annals of Translational Medicine
- Targeting the NLRP3 inflammasome in cardiovascular diseases
- (2021) Stefano Toldo et al. PHARMACOLOGY & THERAPEUTICS
- Soluble Uric Acid Promotes Atherosclerosis via AMPK (AMP-Activated Protein Kinase)-Mediated Inflammation
- (2020) Yoshitaka Kimura et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis
- (2020) Sha-Sha Xing et al. INFLAMMATION
- Gut Microbiota and Its Metabolites in Atherosclerosis Development
- (2020) Magdalena D. Pieczynska et al. MOLECULES
- Salvianolic Acid A Ameliorates Early-Stage Atherosclerosis Development by Inhibiting NLRP3 Inflammasome Activation in Zucker Diabetic Fatty Rats
- (2020) Quanxin Ma et al. MOLECULES
- Devouring atherosclerotic plaques
- (2020) Gabrielle Fredman Nature Nanotechnology
- NLRP3 Inflammasome—A Key Player in Antiviral Responses
- (2020) Chunyuan Zhao et al. Frontiers in Immunology
- Genetic Hearing Loss Associated With Autoinflammation
- (2020) Hiroshi Nakanishi et al. Frontiers in Neurology
- Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
- (2020) Antonio Abbate et al. CIRCULATION RESEARCH
- Natural Compounds as Sustainable Additives for Biopolymers
- (2020) Nadka Tzankova Dintcheva et al. Polymers
- Calcium deposition within coronary atherosclerotic lesion: Implications for plaque stability
- (2020) Hiroyuki Jinnouchi et al. ATHEROSCLEROSIS
- Acute myocardial infarction and large coronary thrombosis in a patient with COVID‐19
- (2020) Delio Tedeschi et al. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
- FGF21 mitigates atherosclerosis via inhibition of NLRP3 inflammasome-mediated vascular endothelial cells pyroptosis
- (2020) Zhaolin Zeng et al. EXPERIMENTAL CELL RESEARCH
- Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction
- (2020) Max J. M. Silvis et al. Journal of Cardiovascular Translational Research
- NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
- (2020) Shaima'a Hamarsheh et al. Frontiers in Immunology
- Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis
- (2020) Chih-Sheng Chu et al. Biomedicines
- Intracoronary imaging identifies plaque rupture underlying left main thrombosis in acute myocardial infarction without angiographically evident atherosclerosis
- (2020) Baskaran Chandrasekar et al. EUROPEAN HEART JOURNAL
- The NLRP3 inflammasome: Mechanism of action, role in disease and therapies
- (2020) Li Wang et al. MOLECULAR ASPECTS OF MEDICINE
- Inflammation in Atherosclerosis—No Longer a Theory
- (2020) Peter Libby CLINICAL CHEMISTRY
- Cadmium exposure induces endothelial dysfunction via disturbing lipid metabolism in human microvascular endothelial cells
- (2020) Hao Liang et al. JOURNAL OF APPLIED TOXICOLOGY
- Inhibiting the NLRP3 Inflammasome
- (2020) Lina Y. El-Sharkawy et al. MOLECULES
- BDNF corrects NLRP3 inflammasome-induced pyroptosis and glucose metabolism reprogramming through KLF2/HK1 pathway in vascular endothelial cells
- (2020) Hong Jin et al. CELLULAR SIGNALLING
- Advances in biological therapies for dyslipidemias and atherosclerosis
- (2020) Eftaxia-Konstantina Valanti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Biological Functions of Autophagy Genes: A Disease Perspective
- (2019) Beth Levine et al. CELL
- Immunity and Inflammation in Atherosclerosis
- (2019) Dennis Wolf et al. CIRCULATION RESEARCH
- Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
- (2019) Yang Yang et al. Cell Death & Disease
- The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
- (2019) Nathan Kelley et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA‐181a regulates the activation of the NLRP3 inflammatory pathway by targeting MEK1 in THP‐1 macrophages stimulated by ox‐LDL
- (2019) Jinyang Song et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Myocardial Infarction—From Atherosclerosis to Thrombosis
- (2019) Jathushan Palasubramaniam et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Innate immunity signalling and membrane trafficking
- (2019) Tomohiko Taguchi et al. CURRENT OPINION IN CELL BIOLOGY
- Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors
- (2019) Katharina Lechner et al. European Journal of Preventive Cardiology
- Macrophage polarization in atherosclerosis
- (2019) Sai Yang et al. CLINICA CHIMICA ACTA
- [Gly14]‐Humanin Prevents Lipid Deposition and Endothelial Cell Apoptosis in a Lectin‐like Oxidized Low‐density Lipoprotein Receptor‐1‐Dependent Manner
- (2019) Yu Ding et al. LIPIDS
- Pharmacological Inhibitors of the NLRP3 Inflammasome
- (2019) Ayesha Zahid et al. Frontiers in Immunology
- Macrophages in Atherosclerosis Regression
- (2019) Tessa J. Barrett ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome‐related inflammation and modulating cholesterol transport
- (2019) Jinque Luo et al. FASEB JOURNAL
- Antiphosholipid syndrome and the risk of myocardial infarction: current evidence and uncertainties
- (2019) Linda Lóczi et al. Kardiologia Polska
- Atherosclerosis and inflammation: overview and updates
- (2018) Glaucylara Reis Geovanini et al. CLINICAL SCIENCE
- Molecular Targets and Natural Compounds in Drug Development for the Treatment of Inflammatory Pain
- (2018) Anna Woodbury et al. CURRENT DRUG TARGETS
- The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2
- (2018) Dimitry A. Chistiakov et al. IMMUNOBIOLOGY
- MicroRNA
- (2018) Thomas X. Lu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis
- (2018) Peng Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- TanshinoneIIA Alleviates Inflammatory Response and Directs Macrophage Polarization in Lipopolysaccharide-Stimulated RAW264.7 Cells
- (2018) Shan Gao et al. INFLAMMATION
- Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
- (2018) Luigi Ferrucci et al. Nature Reviews Cardiology
- Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition
- (2018) Sai Ma et al. Oxidative Medicine and Cellular Longevity
- Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease
- (2018) Eithne M. Maguire et al. VASCULAR PHARMACOLOGY
- LongShengZhi capsule reduces established atherosclerotic lesions in apoE deficient mice by ameliorating hepatic lipid metabolism and inhibiting inflammation
- (2018) Jing Ma et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Animal models of atherosclerosis
- (2017) Besa Emini Veseli et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Role of NLRP3 Inflammasomes in Atherosclerosis
- (2017) Tadayoshi Karasawa et al. Journal of Atherosclerosis and Thrombosis
- NLRP3 inflammasome: Its regulation and involvement in atherosclerosis
- (2017) Zahra Hoseini et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Dietary PUFAs attenuate NLRP3 inflammasome activation via enhancing macrophage autophagy
- (2017) Lulu Shen et al. JOURNAL OF LIPID RESEARCH
- Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis
- (2017) Ismail Sergin et al. Nature Communications
- The roles of macrophage autophagy in atherosclerosis
- (2016) Bo-zong Shao et al. ACTA PHARMACOLOGICA SINICA
- NLRP3 inflammasome: a novel link between lipoproteins and atherosclerosis
- (2016) Wang Li Li et al. Archives of Medical Science
- Macrophage Phenotype and Function in Different Stages of Atherosclerosis
- (2016) Ira Tabas et al. CIRCULATION RESEARCH
- Roles of microRNA and signaling pathway in osteoarthritis pathogenesis
- (2016) Bin Xu et al. Journal of Zhejiang University-SCIENCE B
- Coronary Endothelial Dysfunction Induced by Nucleotide Oligomerization Domain-Like Receptor Protein with Pyrin Domain Containing 3 Inflammasome Activation During Hypercholesterolemia: Beyond Inflammation
- (2015) Yang Zhang et al. ANTIOXIDANTS & REDOX SIGNALING
- Molecular mechanisms regulating NLRP3 inflammasome activation
- (2015) Eun-Kyeong Jo et al. Cellular & Molecular Immunology
- Anti-Inflammatory and Antiatherogenic Effects of the NLRP3 Inflammasome Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet
- (2015) A. Abderrazak et al. CIRCULATION
- A review: microRNA detection methods
- (2015) Tian Tian et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- CAPS — pathogenesis, presentation and treatment of an autoinflammatory disease
- (2015) Jasmin B. Kuemmerle-Deschner Seminars in Immunopathology
- Overview of MicroRNA Biology
- (2015) Ashley Mohr et al. SEMINARS IN LIVER DISEASE
- The Chemokine System in Innate Immunity
- (2015) Caroline L. Sokol et al. Cold Spring Harbor Perspectives in Biology
- NLRP3 inflammasome and its inhibitors: a review
- (2015) Bo-Zong Shao et al. Frontiers in Pharmacology
- Pathogenesis of acute stroke and the role of inflammasomes
- (2013) David Yang-Wei Fann et al. AGEING RESEARCH REVIEWS
- An Overview of Autophagy: Morphology, Mechanism, and Regulation
- (2013) Katherine R. Parzych et al. ANTIOXIDANTS & REDOX SIGNALING
- Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations
- (2013) Randall C Thompson et al. LANCET
- Autophagy Links Inflammasomes to Atherosclerotic Progression
- (2012) Babak Razani et al. Cell Metabolism
- A VLP-based vaccine against interleukin-1α protects mice from atherosclerosis
- (2012) Alain C. Tissot et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Myocardial infarction accelerates atherosclerosis
- (2012) Partha Dutta et al. NATURE
- Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
- (2011) Paul M Ridker et al. AMERICAN HEART JOURNAL
- Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis
- (2011) Stefan Freigang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Canakinumab: a human anti-IL-1β monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes
- (2010) Leigh D Church et al. Expert Review of Clinical Immunology
- Autophagy: cellular and molecular mechanisms
- (2010) Danielle Glick et al. JOURNAL OF PATHOLOGY
- Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation
- (2010) Kristiina Rajamäki et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More